Investors in Hologic, Inc. (NASD: HOLX) saw new options become available today, for the July expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the HOLX options chain for the new July contracts and identified one put ...

... that are Abbott Laboratories (NYSE:ABT) having profit margin 3.58%, Medtronic, Inc. (NYSE:MDT) with 20.61% profit margin, St. Jude Medical, Inc. (NYSE:STJ) having 9.78% profit margin and Hologic, Inc. (NASDAQ:HOLX) having profit margin of -4.23%.

Hologic, Inc.'s YTD performance was recorded as 267.70% while its market capitalization was $5.53 billion. The company has P/B ratio of 1.85.

Vote up. loading. (RTTNews.com) - Hologic Inc ( HOLX ) will present at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas, Nevada .

Rosenman was Senior Vice President and Chief Financial Officer of Gen-Probe, Inc., from 2001, through its IPO in 2002, until its acquisition by Hologic, Inc., in August 2012 for $3.7 billion. His financial expertise and knowledge of public healthcare ...

BEDFORD -- Shares of Hologic Inc. were down in early after-hours trading Monday after the company reported lower-than-expected revenues for its fiscal second quarter and lowered its guidance for the year.

Hologic, Inc. published the final results of a prospective large-scale study comparing cancer screening breast realized using mammography 2D associated tomosynthesis Hologic (breast Tomosynthesis) and mammography conventional 2D.

The Corporation has also granted a worldwide exclusive license to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. operating as Hologic Gen-Probe, for the development and commercialization of a prostate cancer test using PCA3, DiagnoCure's ...

Patina's client roster includes Johnson Controls, Land's End, Hologic Inc., Tenneco Inc., and State Street Bank. Patina reported revenue of about $10 million in 2012 and $15 million in projected revenue for 2013.

Boston, MA -- (SBWIRE) -- 05/08/2013 -- GlobalData's new report, "PerkinElmer, Inc. Market Share Analysis" provides in-depth information on PerkinElmer, Inc.'s market position in the different medical equipment markets it operates in.